Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
BACKGROUND
A simple and non-invasive methods for the diagnosis of transitional cell carcinoma of the bladder are needed for the prevention of invasive tumor. A proteomic technology has recently been developed to facilitate protein profiling of biological mixtures. We tried to detect the marker proteins by proteomic approach during the initiation stages on N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-induced bladder carcinogenesis in rats.


METHODS
Ten rats in group A were given 0.05% BBN in drinking water for 12 weeks. Other 10 rats in group B with 10 rats were designated as a control group and were not given BBN. Whole urinary bladders of all rats were excised at 12 weeks from the beginning of the experiment. Conventional proteomics was performed with high resolution 2-dimension gel electrophoresis followed by computational image analysis and protein identification using mass spectrometry.


RESULTS
A comparison of urinary bladder hyperplasia tissue with control tissue showed that five proteins; actin gamma2 propeptide, cytokeratin-20 (CK-20), proapolipoprotein, alpha2 actin (alpha-cardiac actin) and heat shock 27 kDa protein-1 were over-expressed in hyperplastic tissues. Three proteins; transcription factor myocardin, seminal vesicle secretory protein VI (SVS-VI) precursor and hypothetical protein RMT-7 were under-expressed in hyperplastic tissues.


CONCLUSIONS
In our animal mode, BBN-induced urinary bladder mucosal hyperplasia resulted in an increase in the expression of five proteins and a decrease in the expression of three proteins. Of these, CK-20 and SVS-VI seem to be of particular interest. However other method such as Western blotting seems to be needed for confirmation of these proteins and more information on human bladder tissue is needed for clinical application.
Department of Urology, College of Medicine, Dankook University, Cheonan, Korea. bluesky@dku.edu
Hyung-Jee
HJ
Kim
Inho
I
Sohng
Cheol-Ho
CH
Hwang
Ji-Young
JY
Park
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002085:Butylhydroxybutylnitrosamine / Q000008:administration & dosage; D053554:Keratin-20; D007633:Keratins / Q000032:analysis*; D008297:Male; D011230:Precancerous Conditions / Q000139:chemically induced / Q000737:chemistry* / Q000473:pathology; D040901:Proteomics; D051381:Rats; D017207:Rats, Sprague-Dawley; D029607:Seminal Vesicle Secretory Proteins / Q000032:analysis*; D001749:Urinary Bladder Neoplasms / Q000737:chemistry*
D015415:Biomarkers; C507499:KRT20 protein, human; D053554:Keratin-20; D029607:Seminal Vesicle Secretory Proteins; C101178:Svs4 protein, rat; D002085:Butylhydroxybutylnitrosamine; D007633:Keratins